Prognostic Impact of Sarcopenia on Clinical Outcomes in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With Immune Checkpoint Inhibitors
These findings underscore the detrimental impact of sarcopenia on the efficacy of immune checkpoint inhibitor therapy in patients with recurrent and/or metastatic HNSCC. Careful consideration of sarcopenia is warranted in the clinical management of these patients.
Authors
- M Umemoto
- TAKAYUKI KIMURA
- MUTSUKAZU KITANO
- Takahiro Wakasaki (ORCID: https://orcid.org/0000-0001-7736-9162)
- Ryuji Yasumatsu (ORCID: https://orcid.org/0000-0001-6199-0341)
- KAZUHIRO MIYAMOTO
- Mitsuo Satõ (ORCID: https://orcid.org/0000-0003-4498-7428)
- Daisuke Abe (ORCID: https://orcid.org/0000-0002-6160-7223)
- Satoru Koike
Institutions
- Kindai University Hospital (JP)
- Kindai University (JP)
Publication Details
- Journal
- Cancer Diagnosis & Prognosis
- Published
- 2025-09-01
- DOI
- https://doi.org/10.21873/cdp.10474
- Citations
- 2
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 2.33
Funders
- Japan Society for the Promotion of Science